MI-mAbs, a privileged partner of the Master of Immunology at Aix-Marseille University

Today, monoclonal antibodies are the major class of drugs in oncology and inflammation. Together with the rise of antibody-based tools for research and diagnostics, their development has led to a renewed need of engineers and PhD students mastering basic and applied immunology, with specific knowledge in monoclonal antibody development. Accordingly, MI-mAbs has undertaken the mission of participating to the training of new professionals in the field, in partnership with Aix-Marseille University.

Marseille has a long tradition of excellence in the field of immunology, with world-renowned research centers (CIML and CRCM), and biotech companies (Innate Pharma, HalioDX, Beckman Coulter) focused on this field. Historically, Aix-Marseille University has trained a number of Master and PhD immunology students.

In keeping with the excellence in this area, Aix-Marseille University has renewed its engagement towards the advancement of immunology with a dedicated Master Program. It offers solid foundations in basic and applied immunology to students with an international background who can pursue a career with a PhD in immunology or an engineer’s degree in immunotechnology. These courses are at the heart of two scientific, technological and medical revolutions: monoclonal antibodies and immunotherapy. Students are in contact with key leaders in fundamental immunology, technology platforms (mice genetic engineering and immunophenotyping, mAb engineering) and biotech companies throughout their courses and training periods.

Led by François Romagné, Professor of immunology who teaches Master students at the University, MI-mAbs contributes to student training in immunotechnology, in particular with respect to the generation, engineering and use of monoclonal antibodies in research, diagnostics and therapeutics. MI-mAbs teaching program includes courses and workshops, as well as hands-on training in different aspects of immunotechnology.

At the forefront of the current revolution around immunotechnologies, Marseille has created a strong "basic, translational, industrial and clinical immunology" continuum embodied in the cluster Marseille Immunopôle (MI). In this framework, MI-mAbs’ teaching program is a key player within the ambitious project that is MI, making of Marseille a leading place for the development of immunotherapy antibodies and the host for one of the best schools of immunology in the world.